Tim Rich serves as vice president and leads the consultancy, innovation, and strategy group, which is a driving force behind the adoption of decentralized strategies while bringing forward novel solutions. Prior to his appointment, Rich was a member of PPD’s biotech operational leadership group. In this role, he provided strategic direction, leadership, and management across multiple divisions and therapeutic areas by leveraging more than 20 years of experience in project delivery that covers a wide range of indications –- including complex rare disease and gene therapy programs. Rich joined PPD in 2006, working in project management and eventually progressing to his current leadership role. In total, his experience spans a variety of areas in the clinical trial space, such as global project management, portfolio management, development operations, and client relationship roles.